companydata.dkSYNACT PHARMA ApS: Financial statements 2017
CVR: 34459975
SYNACT PHARMA ApS (CVR 34459975) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -9,991,876 and a net result of DKK -8,278,722 compared with DKK -8,884,785 the year before. Equity amounted to DKK 1,646,605. The solvency ratio was 16.3%.
- Gross Profit
- -9,991,876 kr.
- Profit/Loss
- -8,278,722 kr.
- Equity
- 1,646,605 kr.
- Total Assets
- 10,091,051 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -10 mio. | -8.3 mio. | 1.6 mio. | - |
| 2016 | - | -9.9 mio. | -8.9 mio. | 9.9 mio. | - |
| 2015 | - | -309 t. | -783 t. | -3.9 mio. | - |
| 2014 | - | -343 t. | -768 t. | -3.1 mio. | - |
| 2013 | - | -953 t. | -1.1 mio. | -2.3 mio. | - |
Find more companies like SYNACT PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
SYNACT PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -9,884,650, and the net result was DKK -8,884,785.
About SYNACT PHARMA ApS
SYNACT PHARMA ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SYNACTION PHARMA ApS. The management consists of Jeppe Øvli Øvlesen, Thomas Boesen and Ann Kristin Brøgger Led. The company is owned by SynAct Pharma AB. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity amounted to DKK 20,295,649.